Cellectar Biosciences Inc

+0.01 (+2.08%)
Earnings Announcements

Cellectar Reports Financial Results For First Quarter 2022

Published: 05/10/2022 13:04 GMT
Cellectar Biosciences Inc (CLRB) - Cellectar Reports Financial Results for First Quarter 2022 and Provides a Corporate Update.
Cellectar Biosciences Inc - Qtrly Loss per Share $0.10.
Cellectar Biosciences Inc - As of March 31, 2022, Company Had Cash and Cash Equivalents of $30.6 Million.
Cellectar - Believes Cash on Hand Adequate to Fund Basic Budgeted Operations for at Least 12 Months From Filing of Q1 2022 Financial Statements.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.10

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.10

More details on our Analysts Page.